Skip to main contentSkip to navigation
Sirius Investors
Bausch + Lomb Corporation

Bausch + Lomb Corporation

BLCO
NYSEHealthcare

Bausch + Lomb Corporation (BLCO) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Bausch + Lomb Corporation's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
-16.75
Burn Risk
P/B Ratio
0.94
Strong
WeakModerateStrong
Earnings Yield
-5.96%
Yield Gap

Profitability Health

2025
Return on Equity
-5.58%
Weak
WeakModerateStrong
Operating Margin
3.69%
Weak
WeakModerateStrong
Net Profit Margin
-7.06%
Weak
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
6.47%
Moderate
WeakModerateStrong
Net Income Growth
-13.56%
Weak
WeakModerateStrong
EPS Growth
-13.33%
Weak
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
1.55
Moderate
WeakModerateStrong
Quick Ratio
1.04
Moderate
WeakModerateStrong
Asset Turnover
0.36x
Weak
WeakModerateStrong
Inventory Turnover
2.36x
Weak
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
-1.09%
Weak
WeakModerateStrong
EV / Free Cash Flow
-167.12x
Strong
WeakModerateStrong
Net Debt / EBITDA
9.32x
Weak
WeakModerateStrong
Interest Burden (EBT / EBIT)
-1.686
Weak
WeakModerateStrong
Return on Invested Capital
1.54%
Weak
WeakModerateStrong
Cash Conversion Cycle
180.36 days
Weak
WeakModerateStrong

Fortress screener guardrails

0/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for BLCO.

View Financial Statements